Business
Single-shot Johnson & Johnson vaccine ‘highly effective’ in preventing severe COVID-19 – SBS News
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa,…
The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administration.
The news on Wednesday came as the US regulator was set to convene an independent panel Friday that will likely vote to authorise the vaccine, making it the third available in the country hit hardest by the coronavirus pandemic.
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe…
-
Business12 hours agoHere’s Warren Buffett’s advice as stocks reach record highs
-
Noosa News24 hours agoGutted Broadway Hotel in Woolloongabba set for restoration … and a new high-rise tower
-
Noosa News23 hours agoWhat Halloween decoration is accused of endangering birds? Take the Brisbane Times Quiz
-
General12 hours agoDemography Manifest